The trademark application DOING WELL BY DOING GOOD was filed by Celgene Corporation, a U.S. corporation (the "Applicant"). Application withdrawn.
The application was filed in English (French was selected as the second language).
The Refusal with reference B 005844642 was Rejected according to Article 7(1)(b) CTMR with decision issued on October 5, 2007 by the EUIPO.
Goods And Services
The mark was filed in class 5 with following description of goods:
Biological preparations for medical purposes, including for use in the treatment of immunological, inflammatory and neurological disorders
Pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment of diseases
Biological preparations for use in medicinal tests, inoculations, and treatment of diseases, including immonological, inflammatory and neurological disorders and cancer
Culture media, including tissue culture media and bacteriogical culture media for medical use
Medicinal and biological preparations for pharmaceutical and clinical use, including preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system.
The mark was filed in class 42 with following description of goods:
Research in the fields of chemicals and pharmaceuticals
Product safety testing in the fields of chemicals and pharmaceuticals
Research and development of new products for others in the fields of chemicals and pharmaceuticals
Providing clinical laboratory testing services, including pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping base on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries
Providing medical and pharmaceutical research information
Scientific research services
Design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery
Scientific research, including development of pharmaceuticals or diagnostic methods for others